TY  - GEN
AU  - Schicher,Nikolaus
AU  - Paulitschke,Verena
AU  - Swoboda,Alexander
AU  - Kunstfeld,Rainer
AU  - Loewe,Robert
AU  - Pilarski,Peter
AU  - Pehamberger,Hubert
AU  - Hoeller,Christoph
TI  - Erlotinib and bevacizumab have synergistic activity against melanoma
SN  - 1078-0432
PY  - 2009///0803
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Cell Line
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - drug effects
KW  - Cell Proliferation
KW  - Drug Synergism
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - metabolism
KW  - Female
KW  - Humans
KW  - Immunoblotting
KW  - Immunohistochemistry
KW  - Ki-67 Antigen
KW  - analysis
KW  - Lung Neoplasms
KW  - drug therapy
KW  - Melanoma, Experimental
KW  - Mice
KW  - Mice, SCID
KW  - Platelet Endothelial Cell Adhesion Molecule-1
KW  - Proto-Oncogene Proteins c-akt
KW  - Quinazolines
KW  - Signal Transduction
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-08-2407
ER  -